Tamsulosin Hydrochloride Capsule
Product Images NDC 57237-014

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 57237-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)

A line graph showing mean plasma concentrations of Tamsulosin Hydrochloride following single-dose administration of 0.4 mg capsules under fasted and fed conditions over 36 hours. The y-axis represents plasma concentration (ng/mL), and the x-axis represents time (hours). Two curves compare concentration levels between fasted (dashed line) and fed (solid line) states.*

FDA Label Image

Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)

A line graph titled 'Figure 2A Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1' showing mean change versus duration of treatment in weeks. The graph compares treatments with Tamsulosin Hydrochloride 0.8 mg and 0.4 mg capsules against placebo. The x-axis marks treatment duration from 0 to 13 weeks and LOCF, and the y-axis denotes mean change from 0 to -11. Both Tamsulosin doses show greater reductions in symptom scores over time compared to placebo.*

FDA Label Image

Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)

A line graph titled 'Figure 2B Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 2' showing mean change in symptom scores over 13 weeks for three treatments: 0.8 mg dose (circles), 0.4 mg dose (triangles), and placebo (squares). The x-axis represents duration of treatment in weeks, and the y-axis represents mean change, ranging from 0 to -11. Sample sizes at each time point are indicated below the x-axis. Both dosing groups show a greater mean decrease in symptom score compared to placebo over the study period.*

FDA Label Image

Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)

A line graph titled 'Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1' displaying mean change over duration of treatment in weeks. It compares three treatment groups: 0.8 mg, 0.4 mg, and placebo, with mean change (mL/sec) on the y-axis and duration of treatment (weeks) on the x-axis. Sample sizes per time point are noted below the x-axis.*

FDA Label Image

Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)

A line graph titled 'Figure 3B Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2' showing mean change in urine flow rate over treatment duration in weeks. It compares three treatments: 0.8 mg, 0.4 mg, and placebo, with data points spanning 0 to 16 weeks. The vertical axis is mean change (mL/sec), and the horizontal axis is treatment duration in weeks.*

FDA Label Image

Package Label-principal Display Panel (0.4 mg (100 Capsule Bottle))

Label for Tamsulosin Hydrochloride Capsules, USP 0.4 mg by Rising Pharma Holdings, Inc. The label states a package size of 100 capsules, for oral use, with an Rx only designation. It includes storage instructions, distributor information showing Rising Health, LLC in Saddle Brook, NJ, and indicates the product is made in India. A barcode is shown on the right side.*

FDA Label Image

Chemical Structure (Tamsulosin Str)

Chemical structure of Tamsulosin Hydrochloride, showing its molecular components including aromatic rings, functional groups, and the hydrochloride salt (HCl) indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.